• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔穿刺术:肝硬化腹水患者管理中的一种重新评估的操作

Paracentesis: a re-evaluated procedure in the management of cirrhotic patients with ascites.

作者信息

Salerno F, Badalamenti S, Incerti P, Moser P, Capozza L, Lorenzano E, Restelli B

机构信息

Istituto di Medicina Interna, Università di Milano, Italy.

出版信息

Ital J Gastroenterol. 1990 Feb;22(1):44-9.

PMID:2131928
Abstract

Paracentesis is the oldest method for treating patients with ascites, but the fear of serious side-effects and the coincident introduction of effective non-toxic diuretic drugs led to its abandonment during the fifties. In recent years, several studies have investigated whether abdominal evacuation of ascitic fluid is truly dangerous for cirrhotic patients. The results of some randomized controlled trials comparing paracentesis with a traditional diuretic therapy showed that the rate of complications after paracentesis, particularly when the procedure was combined with a sufficient plasma expansion, was equal to or lower than that of diuretic treatment. Moreover, the ability of paracentesis to resolve tense ascites, both in terms of number of successes and of time required to obtain ascites resolution, was similar or even higher. These data and the recent new interest of several investigators in employing ascitic fluid examination for diagnostic purposes have increased the use of this procedure in the clinical practice.

摘要

腹腔穿刺术是治疗腹水患者最古老的方法,但由于担心严重的副作用以及同时出现了有效的无毒利尿剂,导致该方法在五十年代被弃用。近年来,多项研究探讨了对肝硬化患者进行腹腔排液是否真的危险。一些将腹腔穿刺术与传统利尿疗法进行比较的随机对照试验结果表明,腹腔穿刺术后的并发症发生率,尤其是在该操作与充分的血浆扩容相结合时,等于或低于利尿治疗的并发症发生率。此外,腹腔穿刺术在解决张力性腹水方面,无论是成功的次数还是腹水消退所需的时间,都相似甚至更高。这些数据以及最近一些研究人员对将腹水检查用于诊断目的的新兴趣,增加了该操作在临床实践中的应用。

相似文献

1
Paracentesis: a re-evaluated procedure in the management of cirrhotic patients with ascites.腹腔穿刺术:肝硬化腹水患者管理中的一种重新评估的操作
Ital J Gastroenterol. 1990 Feb;22(1):44-9.
2
[Paracentesis combined with albumin infusion in the treatment of tense ascites in cirrhotic patients].[腹腔穿刺术联合白蛋白输注治疗肝硬化患者的张力性腹水]
Rev Med Chil. 1990 Aug;118(8):874-80.
3
Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.肝硬化腹水的治疗。利尿剂、腹腔静脉分流术及大量腹腔穿刺放液术。
Gastroenterol Clin North Am. 1992 Mar;21(1):237-56.
4
Prospective study comparing human albumin vs. reinfusion of ultrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites.一项前瞻性研究,比较人血白蛋白与在肝硬化合并顽固性腹水患者进行完全腹腔穿刺放液后回输超滤后的腹水。
Z Gastroenterol. 2001 Jan;39(1):5-10. doi: 10.1055/s-2001-10707.
5
Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.Child-Pugh C级肝硬化患者对体位、体育锻炼及腹水治疗的临床和神经体液反应:随机前瞻性试验
Croat Med J. 2003 Apr;44(2):178-86.
6
Mannitolum infusion on cirrhotic patients with tense ascites treated by paracentesis.对接受腹腔穿刺术治疗的肝硬化腹水患者输注甘露醇。
Chin Med J (Engl). 2000 Jan;113(1):27-30.
7
Renaissance of paracentesis in the treatment of ascites.腹腔穿刺术在腹水治疗中的复兴。
Adv Intern Med. 1990;35:365-73.
8
Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites.比较白蛋白和生理盐水预防肝硬化腹水患者穿刺放腹水引起的循环功能障碍的随机试验。
Hepatology. 2003 May;37(5):1147-53. doi: 10.1053/jhep.2003.50169.
9
Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.大量腹腔穿刺放液联合静脉输注白蛋白治疗自发性细菌性腹膜炎患者的长期临床结局:一项随机前瞻性研究
J Gastroenterol Hepatol. 2005 Aug;20(8):1215-22. doi: 10.1111/j.1440-1746.2005.03861.x.
10
Paracentesis in the management of cirrhotic ascites.
J Hepatol. 1993;17 Suppl 2:S14-8. doi: 10.1016/s0168-8278(05)80449-0.